Revvity, Inc.
RVTY NYSEHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Aug 4, 2026
ET
EPS Est.
1.21
EPS Actual
1.41
Revenue Est.
$703M
Revenue Actual
$711M
Next Earnings Report
Date
Oct 26, 2026 · Mon
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
1.29
Revenue Est.
$694.1M
Company Overview
Revvity, Inc. (ticker RVTY) is listed on NYSE with a market cap of about $13.92B. Its next earnings report (FY2026 Q3) is expected on Oct 26, 2026 (ET), Pre-market, with consensus EPS of 1.29. In the last 15 reported quarters, EPS beat consensus estimates 13 times.
Actual EPS TrendRecently15Term · Feb 14, 2023 → Aug 4, 2026
Feb 14, 2023Range: 0.98 ~ 1.70Aug 4, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 4, 2026 | -- | 1.21 | Above forecast↑1.41 | $703M | $711M |
| May 5, 2026 | -- | 1.02 | 1.06 | $704.1M | $711.1M |
| Feb 2, 2026 | -- | 1.57 | 1.70 | $764.9M | $772.1M |
| Oct 27, 2025 | -- | 1.14 | 1.18 | $699.4M | $698.9M |
| Jul 28, 2025 | -- | 1.14 | 1.18 | $699.9M | $720.3M |
| Apr 28, 2025 | -- | 0.96 | 1.01 | $710.8M | $664.8M |
| Jan 31, 2025 | -- | 1.37 | 1.42 | $665.3M | $729.4M |
| Nov 4, 2024 | -- | 1.13 | 1.28 | $679.7M | $684M |
| Jul 29, 2024 | -- | 1.12 | 1.22 | $690.3M | $691.7M |
| Apr 29, 2024 | -- | 0.94 | 0.98 | $647.2M | $649.9M |
| Feb 1, 2024 | -- | 1.15 | 1.25 | $677.9M | $695.9M |
| Oct 30, 2023 | -- | 1.19 | 1.18 | $695.3M | $670.7M |
| Aug 1, 2023 | -- | 1.18 | 1.21 | $696.1M | $709.1M |
| May 11, 2023 | -- | 1.06 | 1.01 | $678.9M | $674.9M |
| Feb 14, 2023 | -- | 1.66 | 1.70 | $1.03B | $741.2M |
Original Filings (SEC)
10-Q2026-08-11 ↗
8-K2026-08-04 ↗
10-Q2026-05-12 ↗
8-K2026-05-05 ↗
8-K2026-05-01 ↗
10-K2026-02-24 ↗
8-K2026-02-02 ↗
8-K2026-01-13 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
